Pfizer Inc. has recalled more than 650,000 bottles of Advil pain-relief medicine because of the potential for a strong odor in the product, according to the Wall Street Journal.
The Journal reports that Pfizer issued the voluntary recall of eight lots of Advil Liqui-Gels bottles to retail-distribution centers only, not at the consumer level. The recall was issued because an element of the manufacturing process “may have caused a stronger odor in the product,” according to a notice posted this week on the U.S. Food and Drug Administration’s website.
No safety concerns were associated with the recall.
The FDA posted a more serious advisory about a Pfizer product, the antibiotic Zithromax, last week.
The FDA notified healthcare professionals of a study published in the New England Journal of Medicine that found patients taking Zithromax, the brand name for azithromycin, are at higher risk for potentially deadly heart problems.
Zithromax is commonly prescribed for pneumonia and other common infections. The FDA announcement emphasizes that patients taking the drug shouldn’t stop without talking to their doctors.
Last year, according to the Wall Street Journal report, Pfizer recalled more than 315,000 packages of Advil Congestion Relief tablets.
If you or a loved one suffered a heart injury while on Zithromax, then you should consider consulting with an attorney who handles pharmaceutical cases.
See the report here: